Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revvity (RVTY)
NYSE:RVTY
Holding RVTY?
Track your performance easily
RVTY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$79.50 - $128.15
Previous Close$121.18
Volume542.03K
Average Volume (3M)868.26K
Market Cap
$14.95B
Enterprise Value$16.99B
Total Cash (Recent Filing)$1.95B
Total Debt (Recent Filing)$4.00B
Price to Earnings (P/E)68.3
Beta1.01
Next Earnings
Oct 29, 2024EPS Estimate
$1.13Next Dividend Ex-Date
Oct 18, 2024Dividend Yield0.23%
Share Statistics
EPS (TTM)1.77
Shares Outstanding123,336,708
10 Day Avg. Volume513,838
30 Day Avg. Volume868,261
Standard Deviation0.09
R-Squared0.34
Alpha-0.00138
Financial Highlights & Ratios
Price to Book (P/B)-10.30
Price to Sales (P/S)5.52
Price to Cash Flow (P/CF)23.60
P/FCF Ratio24.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.27
Enterprise Value/Gross Profit11.03
Enterprise Value/Ebitda42.73
Forecast
1Y Price Target
$129.18Price Target Upside5.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Revvity News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevvity narrowed its revenue range and raised EPS/margin expectations.
Investor SentimentInvestors are rewarding companies that come in-line (or better, obviously), show momentum building in the underlying business, and give the impression that '25 Street EPS estimates have little risk of coming down.
Market TrendsManagement pointed to improving trends for the product segment moving forward, expecting positive growth.
Bears Say
Market ConditionsHeadwinds remain in China, applied genomics, and instruments, despite a cautiously optimistic tone on biopharma.
PurchasingManagement flagged pausing in instrument purchases in China as customers await more clarity on stimulus.
SalesPharma and biotech sales were negatively impacted by continued headcount reduction and general caution.
---
Ownership Overview
1.94% Insiders
39.81% Mutual Funds
54.77% Other Institutional Investors
3.48% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RVTY FAQ
What was Revvity’s price range in the past 12 months?
Revvity lowest stock price was $79.50 and its highest was $128.15 in the past 12 months.
What is Revvity’s market cap?
Currently, no data Available
When is Revvity’s upcoming earnings report date?
Revvity’s upcoming earnings report date is Oct 29, 2024 which is in 52 days.
How were Revvity’s earnings last quarter?
Revvity released its earnings results on Jul 29, 2024. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.122 by $0.098.
Is Revvity overvalued?
According to Wall Street analysts Revvity’s price is currently Undervalued.
Does Revvity pay dividends?
Revvity pays a Quarterly dividend of $0.07 which represents an annual dividend yield of 0.23%. See more information on Revvity dividends here
What is Revvity’s EPS estimate?
Revvity’s EPS estimate is $1.13.
How many shares outstanding does Revvity have?
Revvity has 123,336,710 shares outstanding.
What happened to Revvity’s price movement after its last earnings report?
Revvity reported an EPS of $1.22 in its last earnings report, beating expectations of $1.122. Following the earnings report the stock price went up 9.066%.
Which hedge fund is a major shareholder of Revvity?
Among the largest hedge funds holding Revvity’s share is EdgePoint Investment Group Inc.. It holds Revvity’s shares valued at 209M.
---
Revvity Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$129.18 (5.50% Upside)
$129.18 (5.50% Upside)
Blogger Sentiment
Bullish
RVTY Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $100.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.71%
12-Months-Change
Fundamentals
Return on Equity
2.51%
Trailing 12-Months
Asset Growth
-5.58%
Trailing 12-Months
Company Description
Revvity
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
---
RVTY Company Deck
---
RVTY Earnings Call
Q2 2024
0:00 / 0:00
---
RVTY Revenue Breakdown
53.02% Diagnostics
46.98% Life sciences
---
RVTY Stock 12 Month Forecast
Average Price Target
$129.18
▲(5.50% Upside)
Technical Analysis
Best Analysts Covering RVTY
1 Year
1 Year Success Rate
19/30 ratings generated profit
1 Year Average Return
+10.70%
reiterated a buy rating last month
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 63.33% of your transactions generating a profit, with an average return of +10.70% per trade.
---